Pharmafile Logo

Unrivalled Convenience – Perks of Virtual Medical Education

Explore the unrivalled convenience of virtual collaboration in medical education with our new series, “Perks of Virtual Medical Education.” Learn why this flexible, efficient mode of learning is the future and how it’s reshaping professional interactions in healthcare. Watch now for insights on making the most of virtual education!

Discover the unmatched convenience of virtual collaboration in the first installment of our Perks of Virtual Medical Education, where we dive into reasons why virtual insight gathering is not only convenient for Medical Education, but it’s the future. Learn why this mode of interaction has become a staple in the modern professional landscape.

Explore the primary reasons why virtual collaboration remains indispensable, pandemic or not. From saving time on commutes to enhancing work-life balance, virtual collaboration facilitates a more flexible and efficient way of learning and interaction among healthcare professionals.

For more insights into the advantages of virtual medical education and to enhance your virtual engagement strategies, visit our blog: https://www.impetusdigital.com/2020/09/17/top-10-reasons-why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/

Enhance your virtual engagements with Impetus Digital:

Stay connected:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Improving Health Through Integrated & Personalized Patient Care

Hicham Naim, Global Head, Integrated & Personalized Patient Care Program, Digital Advisory Board at Takeda & Founder of Curated Health, explores digital medicine & biomarkers, outcomes-based business models, Software as...

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand

The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...

Investigating the Complexities of the Canadian & Global Health Systems

The Honourable Tony Clement, Co-chair at Reshoring Canada and former Minister of Health, discusses digital transformation, the importance of onshore manufacturing and supply chain operations in Canada, current pharmaceutical regulatory...

Impetus Digital Overview

Virtual engagement experts helping life science companies have ongoing conversations with their customers through our best-in-class online collaboration tools. Best-In-Class Collaboration Technology Impetus Digital provides two turn-key software solutions through...

Using Technology-Enabled Human Interactions to Transform the Home into a Site of Care

Sara Aghvami, Director of Best Buy Health at Best Buy Canada, explores the concept of “helpful homes” and the role of digital health in enabling “aging in place.” She also...

Realizing the Potential of Genomics-Driven Precision Medicine

Jennifer Helfer, Senior Director, Patient Advocacy & Engagement at Encoded Therapeutics Inc., discusses genomics-driven precision medicine, gene therapy misconceptions and fears, involving patients and caregivers in designing gene therapy trials,...

Helping Patients Become Active Participants in Their Own Care

Rishi Nayyar, Co-founder & CEO of PocketHealth, explores how releasing medical imaging records straight to patients can result in data moving more ethically, easily, and securely. He also shares his...

Virtual Speaker Program: A Customer Story

Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions.

Impact of COVID-19 on the Biopsychosocial Model of Health

Dr. Tarry Ahuja, Manager of Program Development in Pharmaceutical Reviews and Senior RWE Advisor at CADTH, explores the impact of COVID-19 on the biopsychosocial model of health, key opportunities and...

Leaders in Pharma: Fran Milnes

In this episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Fran Milnes. She is currently the Head of Marketing and Commercial Excellence in Oncology at Novartis.